Tag: cisplatin
Cisplatin: Trade name Platinol, a platinum-based chemotherapy drug. Other platinum-based chemotherapy drugs include carboplatin (Paraplatin) and oxaliplatum (Eloxatin).
News
11/10/15
Black cumin increases the effectiveness of many types of breast cancer treatment 09/19/15
Ferritin can protect breast cancer cells from treatment by Adriamycin 07/06/15
Breast cancer diet during cisplatin chemotherapy 04/13/15
Fish oil supplements and some fatty fish could reduce effectiveness of chemotherapy 04/10/12
Resveratrol increases the effectiveness of Taxol in triple negative cells 02/15/12
Grapes and other foods might help protect against Adriamycin-induced heart damage 01/17/12
Apigenin increases effectiveness of Taxol chemotherapy 09/13/11
Some fish oil supplements could interfere with effectiveness of chemotherapy 07/11/11
Taking Celebrex might reduce the effectiveness of chemotherapy for breast cancer 06/28/11
Triple negative breast cancer responds to treatments depending on gene expression 01/05/10
Pomegranate compounds inhibit aromatase and reduces breast cancer cell proliferation
Studies
Resveratrol decreases Rad51 expression and sensitizes cisplatin‑resistant MCF‑7 breast cancer cells Protective effects of curcumin and beta-carotene on cisplatin-induced cardiotoxicity: An experimental rat model Curcumin increases breast cancer cell sensitivity to cisplatin by decreasing FEN1 expression Cisplatin is retained in the cochlea indefinitely following chemotherapy Vanillin as a new modulator candidate for renal injury induced by cisplatin in experimental rats Curcumin re-sensitizes multidrug resistant (MDR) breast cancer to cisplatin through inducing autophagy by decreasing CCAT1 expression The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer Curcumin ameliorates cisplatin-induced nephrotoxicity and potentiates its anticancer activity in SD rats: Potential role of curcumin in breast cancer chemotherapy Safety of herbal medicine use during chemotherapy in patients with ovarian cancer: a “bedside-to-bench” approach Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway Cisplatin Induces Apoptosis via ER-Mediated, Calpain1 Pathway in Triple Negative Breast Cancer Cells Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway Tangeretin attenuates cisplatin-induced renal injury in rats: Impact on the inflammatory cascade and oxidative perturbations Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: role of calcitonin gene-related peptide and insulin-like growth factor-1 Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs Selenium potentiates the anticancer effect of cisplatin against oxidative stress and calcium ion signaling-induced intracellular toxicity in MCF-7 breast cancer cells: involvement of the TRPV1 channel Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase-Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo Sulforaphene Synergistically Sensitizes Cisplatin via Enhanced Mitochondrial Dysfunction and PI3K/PTEN Modulation in Ovarian Cancer Cells Chronic-Leptin Attenuates Cisplatin Cytotoxicity in MCF-7 Breast Cancer Cell Line Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil A New Approach to Reduce Toxicities and to Improve Bioavailabilities of Platinum-Containing Anti-Cancer Nanodrugs Cisplatin in cancer therapy: Molecular mechanisms of action Low Concentration of Quercetin Antagonizes the Cytotoxic Effects of Anti-Neoplastic Drugs in Ovarian Cancer Curcumin as a cancer chemotherapy sensitizing agent Thymoquinone, A Bioactive Component of Black Caraway Seeds, Causes G1 Phase Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells with Mutant p53 Genistein modulates the anti-tumor activity of cisplatin in MCF-7 breast and HT-29 colon cancer cells Comparative In Vivo Evaluations of Curcumin and Its Analog Difluorinated Curcumin Against Cisplatin-Induced Nephrotoxicity Fucoidan extract enhances the anti-cancer activity of chemotherapeutic agents in breast cancer cells Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines Tea Polyphenols Modulate Antioxidant Redox System on Cisplatin-induced ROS Generation in a Human Breast Cancer Cell Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats Priming effect of aspirin for tumor cells to augment cytotoxic action of cisplatin against tumor cells: implication of altered constitution of tumor microenvironment, expression of cell cycle, apoptosis, and survival regulatory molecules Enhancement of cisplatin cytotoxicity by benzyl isothiocyanate in HL-60 cells Piperine protects cisplatin-induced apoptosis via heme oxygenase-1 induction in auditory cells Bisphenol A at Low Nanomolar Doses Confers Chemoresistance in Estrogen Receptor-α-Positive and -Negative Breast Cancer Cells Simultaneous Treatment of Cancer Cells Lines with the Anticancer Drug Cisplatin and the Antioxidant Fucoxanthin Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV3 cells Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer Differential modulation of cisplatin and doxorubicin efficacies in leukemia cells by flavonoids Effects of the olive, extra virgin olive and canola oils on cisplatin-induced clastogenesis in Wistar rats The extract of Prunus persica flesh (PPFE) attenuates chemotherapy-induced hepatotoxicity in mice Cisplatin combination with allyl isothiocyanate, a constituent of cruciferous vegetables, synergistically increases cancer cell death through activation of caspase 3 and downregulation of the antiapoptotic protein Bcl-2 and survivin Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice Cell proliferation of feline and human breast cancer cell types is inhibited by pomegranate juice
TOP